Discover why Medtronic's growth in robotics, AI, & solid fundamentals make it a Buy ahead of earnings. Read my analysis here.
Key Insights Institutions' substantial holdings in Medtronic implies that they have significant influence over ...
Needham & Company LLC restated their hold rating on shares of Medtronic (NYSE:MDT – Free Report) in a research note published on Wednesday morning,Benzinga reports. A number of other analysts have ...
A Medtronic (NYSE:MDT) official said today on LinkedIn that the company won CE mark for its Crescent RA jugular dual lumen ...
How mission plus performance can lead to sustainable success.
At the University of Minnesota's heart lab, millions of dollars of tubing and wires and technology work to keep a living ...
Medtronic will use the technology to develop PEEK interbody spine fusion devices that enhance implant fixation.
In terms of liquidity and interest, the mean open interest for Medtronic options trades today is 942.55 with a total volume of 26,313.00.
Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...
In the closing of the recent trading day, Medtronic (MDT) stood at $92.20, denoting a +0.93% change from the preceding trading day.
Medtronic and Axonics — now part of Boston Scientific — have confidentially settled their long-running IP dispute.
Scientists are now speculating that the first person to live to 150 years may already be among us. But where might this ...